{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:36:35Z","timestamp":1769729795862,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002655","name":"Beckman Coulter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"ANRS MIE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127633","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:49:03Z","timestamp":1755845343000},"page":"127633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Humoral immune response to Covid-19 vaccination in patients with cancer \u2013 Results from the ANRS0001S COV-POPART study"],"prefix":"10.1016","volume":"63","author":[{"given":"Liem Binh","family":"Luong Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyvia","family":"Magloire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Billard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Priou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Arrondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Linassier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Ben Ghezala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Gross-Goupil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Dohollou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Vanhems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Cracowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Leroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Lain\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Barthelemy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Priet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Chalouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Barquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Loubet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"de Lamballerie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Wittkop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Spano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2025.127633_bb0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.20892\/j.issn.2095-3941.2020.0559","article-title":"Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants","volume":"18","author":"Yang","year":"2021","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.vaccine.2025.127633_bb0010","article-title":"Deaths due to COVID-19 in patients with Cancer during different waves of the pandemic in the US","volume":"31","author":"Potter","year":"2023","journal-title":"JAMA Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127633_bb0015","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/infdis\/jiad174","article-title":"COVID-19 vaccination in patients with Cancer and patients receiving HSCT or CAR-T therapy: immune response, real-world effectiveness, and implications for the future","volume":"228","author":"Hall","year":"2023","journal-title":"J Infect Dis"},{"issue":"10241","key":"10.1016\/j.vaccine.2025.127633_bb0020","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127633_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41571-022-00610-8","article-title":"COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety","volume":"19","author":"Fendler","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.vaccine.2025.127633_bb0030","series-title":"Avis n\u00b0 2022.0016\/AC\/SESPEV du 17 mars 2022 du coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 relatif \u00e0 la place d\u2019un deuxi\u00e8me rappel des vaccins contre la COVID-19 dans la strat\u00e9gie vaccinale","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127633_bb0035","series-title":"Avis n\u00b02022.0043\/AC\/SESPEV du 13 juillet 2022 du Coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 relatif \u00e0 la place d\u2019une dose de rappel additionnelle des vaccins contre la Covid-19 dans la strat\u00e9gie vaccinale","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127633_bb0040","series-title":"Avis n\u00b0 2021.0081\/AC\/SESPEV du 18 novembre 2021 du coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 relatif \u00e0 la pertinence d\u2019une extension de la population \u00e9ligible \u00e0 une dose de rappel","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2021"},{"issue":"10316","key":"10.1016\/j.vaccine.2025.127633_bb0045","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127633_bb0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(22)00202-9","article-title":"Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study","volume":"23","author":"Lee","year":"2022","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127633_bb0055","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41591-021-01435-1","article-title":"A French cohort for assessing COVID-19 vaccine responses in specific populations","volume":"27","author":"Loubet","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127633_bb0060","doi-asserted-by":"crossref","first-page":"388.e1","DOI":"10.1016\/j.cmi.2022.10.009","volume":"29","author":"Loubet","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127633_bb0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ijc.34273","article-title":"Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection","volume":"152","author":"La Verde","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2025.127633_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejca.2021.12.025","article-title":"Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer","volume":"163","author":"Debie","year":"2022","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127633_bb0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ccell.2022.02.011","article-title":"Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination","volume":"40","author":"Ehmsen","year":"2022","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127633_bb0080","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/vaccines10101613","article-title":"Immunogenicity after a third COVID-19 mRNA booster in solid Cancer patients who previously received the primary heterologous CoronaVac\/ChAdOx1 vaccine","volume":"10","author":"Luangdilok","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127633_bb0085","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1007\/s00432-023-04961-2","article-title":"Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 omicron BA.1 and subvariants BA.4\/5 and BQ.1.1 after COVID-19 vaccination in cancer patients","volume":"149","author":"Overheu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127633_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100587","article-title":"Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment","volume":"7","author":"Su","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.vaccine.2025.127633_bb0095","first-page":"19","article-title":"Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer consortium","author":"Choueiri","year":"2023","journal-title":"The Lancet Regional Health \u2013 Americas"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127633_bb0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2022.06.012","article-title":"Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer","volume":"40","author":"Ehmsen","year":"2022","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127633_bb0105","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ijc.35162","article-title":"Humoral immune response as an indicator for protection against Covid-19 after anti-SARS-COV2-booster vaccination in hematological and oncological patients","volume":"155","author":"Mainka","year":"2024","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127633_bb0110","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.3390\/ijms24076731","article-title":"Persistence of immune response elicited by three doses of mRNA vaccine against SARS-CoV-2 in a cohort of patients with solid Tumors: a one-year follow-up","volume":"24","author":"Lasagna","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127633_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41590-024-01787-z","article-title":"Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination","volume":"25","author":"Fumagalli","year":"2024","journal-title":"Nat Immunol"},{"issue":"92","key":"10.1016\/j.vaccine.2025.127633_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj9285","article-title":"Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults","volume":"9","author":"Wagstaffe","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2025.127633_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107680","article-title":"Vaccine hesitancy in cancer patients: a rapid review","volume":"111","author":"Butow","year":"2023","journal-title":"Patient Educ Couns"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T03:52:42Z","timestamp":1765857162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":25,"alternative-id":["S0264410X25009302"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127633","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral immune response to Covid-19 vaccination in patients with cancer \u2013 Results from the ANRS0001S COV-POPART study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127633"}}